What Can Cost-Effectiveness Analysis Tell Us About Chimeric Antigen Receptor T-Cell Therapy for Relapsed Acute Lymphoblastic Leukemia?
Year: 2018
Type: editorial
Source: Journal of Clinical Oncology
Authors: Christopher R. Flowers, Scott D. Ramsey
Institutions: Fred Hutch Cancer Center, Winship Cancer Institute
Language: English
Topic: CAR-T cell therapy research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2894581576